Poornima Tyagi
New Delhi, DL, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A quinoline compound inhibits the replication of dengue virus serotypes 1-4 in Vero cells.
Journal: Antiviral therapy
Published: December 15, 2017
A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice.
Journal: PLoS neglected tropical diseases
Published: August 31, 2017
Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies.
Journal: Frontiers in microbiology
Published: July 13, 2015
Cissampelos pareira Linn: Natural Source of Potent Antiviral Activity against All Four Dengue Virus Serotypes.
Journal: PLoS neglected tropical diseases
Published: June 01, 2015
A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture.
Journal: Virology journal
Published: November 18, 2014
Dengue-specific subviral nanoparticles: design, creation and characterization.
Journal: Journal of nanobiotechnology
Published: March 07, 2013
Pichia pastoris-expressed dengue 2 envelope forms virus-like particles without pre-membrane protein and induces high titer neutralizing antibodies.
Journal: PloS one
Published: January 01, 2013
Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2.
Journal: Journal of nanobiotechnology
Published: May 01, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026